Literature DB >> 17543368

Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus.

Tomomi Nakahara1, Paul F Lambert.   

Abstract

Promyelocytic leukemia oncogenic domains (PODs), also called nuclear domain 10 (ND10), are subnuclear structures that have been implicated in a variety of cellular processes as well as the life cycle of DNA viruses including papillomaviruses. In order to investigate the interplay between papillomaviruses and PODs, we analyzed the status of PODs in organotypic raft cultures of human keratinocytes harboring HPV genome that support the differentiation-dependent HPV life cycle. The number of PODs per nucleus was increased in the presence of HPV genomes selectively within the poorly differentiated layers but was absent in the terminally differentiated layers of the stratified epithelium. This increase in PODs was correlated with an increase in abundance of post-translationally modified PML protein. Neither the E2-dependent transcription nor viral DNA replication was reliant upon the presence of PML. Implications of these findings in terms of HPV's interaction with its host are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17543368      PMCID: PMC2777652          DOI: 10.1016/j.virol.2007.04.032

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  86 in total

Review 1.  The transcriptional role of PML and the nuclear body.

Authors:  S Zhong; P Salomoni; P P Pandolfi
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

2.  Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2.

Authors:  P Heino; J Zhou; P F Lambert
Journal:  Virology       Date:  2000-10-25       Impact factor: 3.616

3.  The function of PML in p53-dependent apoptosis.

Authors:  A Guo; P Salomoni; J Luo; A Shih; S Zhong; W Gu; P P Pandolfi
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

4.  Role of SUMO-1-modified PML in nuclear body formation.

Authors:  S Zhong; S Müller; S Ronchetti; P S Freemont; A Dejean; P P Pandolfi
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

Review 5.  Review: properties and assembly mechanisms of ND10, PML bodies, or PODs.

Authors:  G G Maul; D Negorev; P Bell; A M Ishov
Journal:  J Struct Biol       Date:  2000-04       Impact factor: 2.867

6.  Replication but not transcription of simian virus 40 DNA is dependent on nuclear domain 10.

Authors:  Q Tang; P Bell; P Tegtmeyer; G G Maul
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.

Authors:  E R Flores; B L Allen-Hoffmann; D Lee; P F Lambert
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  BLM, the Bloom's syndrome protein, varies during the cell cycle in its amount, distribution, and co-localization with other nuclear proteins.

Authors:  M M Sanz; M Proytcheva; N A Ellis; W K Holloman; J German
Journal:  Cytogenet Cell Genet       Date:  2000

9.  The human papillomavirus type 16 E5 protein modulates ERK1/2 and p38 MAP kinase activation by an EGFR-independent process in stressed human keratinocytes.

Authors:  K Crusius; I Rodriguez; A Alonso
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

10.  Cell cycle regulation of PML modification and ND10 composition.

Authors:  R D Everett; P Lomonte; T Sternsdorf; R van Driel; A Orr
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

View more
  15 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  HPV-16 E7 reveals a link between DNA replication stress, fanconi anemia D2 protein, and alternative lengthening of telomere-associated promyelocytic leukemia bodies.

Authors:  Nicole Spardy; Anette Duensing; Elizabeth E Hoskins; Susanne I Wells; Stefan Duensing
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

Review 3.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

4.  CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traits.

Authors:  Chitra Pattabiraman; Shiyuan Hong; Vignesh K Gunasekharan; Annapurna Pranatharthi; Jeevisha Bajaj; Sweta Srivastava; H Krishnamurthy; Aswathy Ammothumkandy; Venkat G Giri; Laimonis A Laimins; Sudhir Krishna
Journal:  Cancer Res       Date:  2014-09-29       Impact factor: 12.701

5.  Design stars: how small DNA viruses remodel the host nucleus.

Authors:  Mengxi Jiang; Michael J Imperiale
Journal:  Future Virol       Date:  2012-05-01       Impact factor: 1.831

6.  Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.

Authors:  Zhenhua Lin; Anna V Yemelyanova; Ratish Gambhira; Subhashini Jagu; Craig Meyers; Reinhard Kirnbauer; Brigitte M Ronnett; Patti E Gravitt; Richard B S Roden
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

7.  Modulation of PML protein expression regulates JCV infection.

Authors:  Megan L Gasparovic; Melissa S Maginnis; Bethany A O'Hara; Aisling S Dugan; Walter J Atwood
Journal:  Virology       Date:  2009-06-11       Impact factor: 3.616

8.  Virion assembly factories in the nucleus of polyomavirus-infected cells.

Authors:  Kimberly D Erickson; Cedric Bouchet-Marquis; Katie Heiser; Eva Szomolanyi-Tsuda; Rabinarayan Mishra; Benjamin Lamothe; Andreas Hoenger; Robert L Garcea
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

9.  Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes.

Authors:  Claudio Villota; América Campos; Soledad Vidaurre; Luciana Oliveira-Cruz; Enrique Boccardo; Verónica A Burzio; Manuel Varas; Jaime Villegas; Luisa L Villa; Pablo D T Valenzuela; Miguel Socías; Sally Roberts; Luis O Burzio
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

Review 10.  Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.

Authors:  Erin L Reineke; Hung-Ying Kao
Journal:  Int J Biol Sci       Date:  2009-05-22       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.